ESPEROCT subst sèche 2000 UI c solv flac

7680671560046 CH-67156 B02BD02 06.01.1.

Reimbursement limitations:

BLUTPRODUKTE

Calcul des prix des préparations sanguines sur la base du prix « ex factory », …

ESPEROCT subst sèche 2000 UI c solv flac
ESPEROCT subst sèche 2000 UI c solv flac
ESPEROCT subst sèche 2000 UI c solv flac
1 / 3
google

Details

Product number
6715604
CPT
-
Packaging group
-
Unit
1 Durchstechflasche mit Pulver und 1 Fertigspritze mit Lösungsmittel
Composition
Praeparatio cryodesiccata: turoctocogum alfa pegolum 2000 U.I., histidinum, saccharum, polysorbatum 80, natrii chloridum corresp. natrium 14.16 mg, methioninum, calcii chloridum dihydricum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, pro vitro. Solvens: natrii chloridum corresp. natrium 14.16 mg, aqua ad iniectabile q.s. ad solutionem pro 4 ml.

Articles (1)

Esperoct 2000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/12/2024
Patient information leaflet
Français
13/12/2024
Patient information leaflet
Italien
13/12/2024
Professional SmPC
Allemand
13/12/2024
Professional SmPC
Français
13/12/2024
Professional SmPC
Italien
13/12/2024

Detailed composition

Substance Quantity Type Category
PRC
2000.0 UI Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
SOLV
14.16 MG Substance HBESI
PRC
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
14.16 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 1572.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2019

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
67156
Drug name
Esperoct, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
B02BD02
Authorization status
Z
Dispensation category
B
First authorization
30/07/2019
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Hämophilie A

Packaging details

Description (FR)
ESPEROCT subst sèche 2000 UI c solv flac
Description (DE)
ESPEROCT Trockensub 2000 IE c Solv Durchstf
Market launch
30/07/2019
Narcotic (BTM)
No

Other packaging sizes

ESPEROCT subst sèche 500 UI c solv flac
None LEER
View
ESPEROCT subst sèche 1000 UI c solv flac
None LEER
View
ESPEROCT subst sèche 1500 UI c solv flac
None LEER
View
ESPEROCT subst sèche 3000 UI c solv flac
None LEER
View
ESPEROCT subst sèche 4000 UI c solv flac
None LEER
View